help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiGiuseppe, J. A.
Right arrow Articles by Hruban, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiGiuseppe, J. A.
Right arrow Articles by Hruban, R. H.

American Journal of Pathology, Vol 147, 884-888, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma

JA DiGiuseppe, MS Redston, CJ Yeo, SE Kern and RH Hruban
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-6417, USA.

The p53 tumor suppressor gene is mutated in the majority of pancreatic adenocarcinomas, and several studies have suggested that loss of p53 function may contribute to the aggressive clinical behavior of pancreas cancer. Although immunocytochemical accumulation of the p53 gene product has previously been assessed as a marker for p53 mutations in cancers of the pancreas and other organ systems, the relationship between p53 mutations and p53 protein accumulation is variable. The cyclin-dependent kinase inhibitor, p21 (also known as WAF1 and CIP1), is induced by wild-type but not mutant p53, and recent work has implicated p21 as a downstream mediator of the growth-suppressing and apoptosis-promoting functions of wild-type p53. In the present work, we sought to determine whether loss of p21 expression could more precisely identify those tumors with p53 mutations and/or loss, compared with immunocytochemical assessment of p53 protein accumulation. We evaluated p53 and p21 expression immunohistochemically in a series of 21 ductal adenocarcinomas of the pancreas with known p53 mutational status. Diffuse overexpression of p53 was found in 3 of 8 cases (38%) with wild- type p53 and 7 of 13 cases (54%) with p53 mutations with or without loss of heterozygosity at 17p. Surprisingly, expression of p21 correlated neither with p53 mutational status nor with p53 protein expression. In particular, strong p21 expression was seen even in carcinomas in which molecular analysis revealed a frameshift mutation in one allele of p53 and loss of the second. These data suggest that p21 expression in pancreatic adenocarcinoma may also be induced by a p53-independent pathway and that p21 expression, as assessed immunocytochemically, does not reflect the functional status of p53 in these carcinomas.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
A. M. Ab' Saber, L. M. Massoni Neto, C. P. Bianchi, B. B. Ctenas, E. R. Parra, E. M. Eher, J. C. Pereira, T. Takagaki, N. H. Yamaguchi, and V. L. Capelozzi
Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas
Ann. Thorac. Surg., June 1, 2004; 77(6): 1883 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
K. Kahnt, K. Matz-Rensing, P. Hofmann, C. Stahl-Hennig, and F.-J. Kaup
SIV-associated Lymphomas in Rhesus Monkeys (Macaca mulatta) in Comparison with HIV-associated Lymphomas
Vet. Pathol., January 1, 2002; 39(1): 42 - 55.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. V. Biankin, J. G. Kench, A. L. Morey, C.-S. Lee, S. A. Biankin, D. R. Head, T. B. Hugh, S. M. Henshall, and R. L. Sutherland
Overexpression of p21WAF1/CIP1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia
Cancer Res., December 1, 2001; 61(24): 8830 - 8837.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M J Schwerer, A Sailer, K Kraft, K Baczako, and H Maier
Patterns of p21waf1/cip1 expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas
J. Clin. Pathol., November 1, 2001; 54(11): 871 - 876.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Matsutani, A. Yamauchi, R. Takahashi, M. Ueno, K. Yoshikawa, K. Honda, H. Nakamura, H. Kato, H. Kodama, T. Inamoto, et al.
Inverse Correlation of Thioredoxin Expression with Estrogen Receptor- and p53-dependent Tumor Growth in Breast Cancer Tissues
Clin. Cancer Res., November 1, 2001; 7(11): 3430 - 3436.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Mouriaux, C.-A. Maurage, P. Labalette, B. Sablonnière, F. Malecaze, and J.-M. Darbon
Cyclin-Dependent Kinase Inhibitory Protein Expression in Human Choroidal Melanoma Tumors
Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2837 - 2843.
[Abstract] [Full Text]


Home page
JCOHome page
G. Pruneri, L. Pignataro, N. Carboni, R. Buffa, D. Di Finizio, B. M. Cesana, and A. Neri
Clinical Relevance of Expression of the CIP/KIP Cell-Cycle Inhibitors p21 and p27 in Laryngeal Cancer
J. Clin. Oncol., October 1, 1999; 17(10): 3150 - 3159.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. E. Saunders, R. MacKenzie, R. Shipman, E. Fransen, R. Gilbert, and R. C. K. Jordan
Patterns of p53 Gene Mutations in Head and Neck Cancer: Full-Length Gene Sequencing and Results of Primary Radiotherapy
Clin. Cancer Res., September 1, 1999; 5(9): 2455 - 2463.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
P. J. CHIAO, K. K. HUNT, A. M. GRAU, A. ABRAMIAN, J. FLEMING, W. ZHANG, T. BRESLIN, J. L. ABBRUZZESE, and D. B. EVANS
Tumor Suppressor Gene Smad4/DPC4, Its Downstream Target Genes, and Regulation of Cell Cycle
Ann. N.Y. Acad. Sci., June 30, 1999; 880(1): 31 - 37.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Yoshikawa, K. Honda, T. Inamoto, H. Shinohara, A. Yamauchi, K. Suga, T. Okuyama, T. Shimada, H. Kodama, S. Noguchi, et al.
Reduction of BRCA1 Protein Expression in Japanese Sporadic Breast Carcinomas and Its Frequent Loss in BRCA1-associated Cases
Clin. Cancer Res., June 1, 1999; 5(6): 1249 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Shoji, Y. Dobashi, S. Morinaga, S.-X. Jiang, and T. Kameya
Tumor Extension and Cell Proliferation in Adenocarcinomas of the Lung
Am. J. Pathol., March 1, 1999; 154(3): 909 - 918.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Caputi, V. Esposito, A. Baldi, A. De Luca, C. Dean, G. Signoriello, F. Baldi, and A. Giordano
p21waf1/cip1mda-6 Expression in Non-small-cell Lung Cancer: Relationship to Survival
Am. J. Respir. Cell Mol. Biol., February 1, 1998; 18(2): 213 - 217.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. A. Jones and G. J. Gores
Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine
Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1174 - G1188.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.